United States
Print page content Print
Increase text size Decrease text size
Text Size

VANGUARD® Rapid Resp intransal

To Help Prevent The
Preventable

Single-nostril (0.5 mL) respiratory vaccines

Sign in to purchase

Vanguard® Rapid Resp Intranasal

This family of single-nostril (0.5 mL) respiratory vaccines helps protect dogs from key pathogens associated with Canine Infectious Respiratory Disease (CIRD) and can make administration fast and comfortable.

Intranasal Administration

Indications:
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza virus (CPiV) and disease caused by Bordetella bronchiseptica (Bb).

3 antigenic combinations:

  • Bb + CPiV + CAV-2

  • Bb + CPiV

  • Bb only

Canine Infectious Respiratory Disease (CIRD)

Infectious respiratory disease in dogs can be caused by many different pathogens, both bacterial and viral. In most instances, the clinical signs will be identical regardless of the infecting pathogen.

Because co-infections frequently occur and may lead to more severe symptoms, a multivalent immunization protocol can help PREVENT THE PREVENTABLE.

Etiology of CIRD

Efficacy and Safety Studies

VANGUARD® Rapid Resp has been laboratory and field tested to demonstrate efficacy and safety.

Efficacy Study7

Safety Study8

Duration of immunity (DOI) Studies

VANGUARD® Rapid Resp Intranasal vaccines have the first approved 1-year duration of immunity claim for the Bordetella bronchiseptica, CAV-2 and CPiV fractions.

Bordetella bronchiseptica DOI Study9

CAV-2 DOI Study10

CPiV DOI Study11

Prime Boost

The use of intranasal and parenteral vaccines may help provide the best Bordetella bronchiseptica protection.12

  • When the immune system is exposed to antigens via different routes, a more robust immune response may be achieved

  • Mucosal administration followed by systemic vaccination can help to avoid immune exclusion, specifically in seropositive patients13

BRONCHICINE® CAe – The Booster Shot™

  • Monovalent

  • Parenteral

  • Non-infectious14

  • Non-adjuvanted